These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23963335)

  • 1. Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis.
    Jin M; Fu X; Wei Y; Du B; Xu XT; Jiang WJ
    Stroke; 2013 Nov; 44(11):2990-4. PubMed ID: 23963335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).
    Derdeyn CP; Fiorella D; Lynn MJ; Turan TN; Cotsonis GA; Lane BF; Montgomery J; Janis LS; Chimowitz MI;
    Stroke; 2017 Jun; 48(6):1501-1506. PubMed ID: 28455321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of intracranial in-stent restenosis using quantitative magnetic resonance angiography.
    Amin-Hanjani S; Alaraj A; Calderon-Arnulphi M; Aletich VA; Thulborn KR; Charbel FT
    Stroke; 2010 Nov; 41(11):2534-8. PubMed ID: 20930155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.
    Jia B; Zhang X; Ma N; Mo D; Gao F; Sun X; Song L; Liu L; Deng Y; Xu X; Zhang Y; Liu Z; Guan S; Zhang F; Li B; Zheng H; Liu X; Liu Y; Chen K; Shuai J; Wan J; Wang J; Shi X; Li T; Chang B; Liebeskind DS; Yu W; Miao Z;
    JAMA Neurol; 2022 Feb; 79(2):176-184. PubMed ID: 34982098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiographic patterns of Wingspan in-stent restenosis.
    Albuquerque FC; Levy EI; Turk AS; Niemann DB; Aagaard-Kienitz B; Pride GL; Purdy PD; Welch BG; Woo HH; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella DJ
    Neurosurgery; 2008 Jul; 63(1):23-7; discussion 27-8. PubMed ID: 18728565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of residual stenosis on clinical outcome and restenosis after middle cerebral artery stenting.
    Yue X; Xi G; Lu T; Xu G; Liu W; Zhang R; Yin Q; Liu X
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):744-50. PubMed ID: 20927521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of endovascular therapy for symptomatic intracranial atherosclerosis.
    Mazighi M; Yadav JS; Abou-Chebl A
    Stroke; 2008 Jun; 39(6):1766-9. PubMed ID: 18420956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis.
    Zhu SG; Zhang RL; Liu WH; Yin Q; Zhou ZM; Zhu WS; Zhu YL; Xu GL; Liu XF
    Eur J Vasc Endovasc Surg; 2010 Oct; 40(4):499-506. PubMed ID: 20554461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.
    Fiorella D; Chow MM; Anderson M; Woo H; Rasmussen PA; Masaryk TJ
    Neurosurgery; 2007 Aug; 61(2):236-42; discussion 242-3. PubMed ID: 17762735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting.
    Jiang WJ; Yu W; Du B; Gao F; Cui LY
    Stroke; 2011 Jul; 42(7):1971-5. PubMed ID: 21636814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Wingspan Stenting for Severe Symptomatic Atherosclerotic Stenosis of the Middle Cerebral Artery: Analysis of 278 Continuous Cases.
    Zhao T; Zhu WY; Xiong XY; Li J; Wang L; Ding HY; Wei F; Zhou Y; Gong ZL; Cheng SY; Liu Y; Shuai J; Yang QW
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2368-72. PubMed ID: 27324301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor impact on blood flow velocities and clinical outcomes of stented cervical and intracranial stenoses: preliminary observations.
    Moreira T; Michel P; Binaghi S; Hirt L
    Clin Neurol Neurosurg; 2012 Sep; 114(7):922-9. PubMed ID: 22402202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis.
    Shin YS; Kim BM; Suh SH; Jeon P; Kim DJ; Kim DI; Kim BS; Kim KH; Heo JH; Nam HS; Kim YD
    Neurosurgery; 2013 Apr; 72(4):596-604; discussion 604. PubMed ID: 23277374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients.
    Yu SC; Leung TW; Lee KT; Wong LK
    J Neurointerv Surg; 2014 Apr; 6(3):212-8. PubMed ID: 23516268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong.
    Man BL; Fu YP; Chan YY; Lam W; Hui CF; Leung WH; Wong KS
    Cerebrovasc Dis; 2009; 28(2):112-8. PubMed ID: 19506369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
    Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L;
    JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study.
    Siddiq F; Vazquez G; Memon MZ; Suri MF; Taylor RA; Wojak JC; Chaloupka JC; Qureshi AI
    Stroke; 2008 Sep; 39(9):2505-10. PubMed ID: 18658032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.
    Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI
    Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid angioplasty and stenting is safe and effective for treatment of recurrent stenosis after eversion endarterectomy.
    Radak D; Tanaskovic S; Sagic D; Antonic Z; Babic S; Popov P; Matic P; Rancic Z
    J Vasc Surg; 2014 Sep; 60(3):645-51. PubMed ID: 24794275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.